These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42 related articles for article (PubMed ID: 2967572)
1. [Expression of the gene for the atrial natriuretic factor: a marker for ventricular hypertrophy]. Drouin J; Lavigne JP; Nemer M Union Med Can; 1988 Feb; 117(1):64-7. PubMed ID: 2967572 [No Abstract] [Full Text] [Related]
2. [Expression of left ventricular ANF-gene in rat with cardiac hypertrophy]. Xia L; Dong MG; Xu DL; Yang H; Tang CS; Tang J Sheng Li Xue Bao; 1993 Apr; 45(2):130-5. PubMed ID: 8356468 [TBL] [Abstract][Full Text] [Related]
3. Differential expression of natriuretic peptides and their receptors in volume overload cardiac hypertrophy in the rat. Su X; Brower G; Janicki JS; Chen YF; Oparil S; Dell'Italia LJ J Mol Cell Cardiol; 1999 Oct; 31(10):1927-36. PubMed ID: 10525429 [TBL] [Abstract][Full Text] [Related]
5. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy. Brito D; Matias JS; Sargento L; Cabral MJ; Madeira HC Rev Port Cardiol; 2004 Dec; 23(12):1557-82. PubMed ID: 15732658 [TBL] [Abstract][Full Text] [Related]
6. SRF-dependent gene expression in isolated cardiomyocytes: regulation of genes involved in cardiac hypertrophy. Nelson TJ; Balza R; Xiao Q; Misra RP J Mol Cell Cardiol; 2005 Sep; 39(3):479-89. PubMed ID: 15950986 [TBL] [Abstract][Full Text] [Related]
7. Molecular characterisation of neonatal cardiac hypertrophy and its regression. Gopinath B; Trent RJ; Yu B Cardiol Young; 2004 Oct; 14(5):498-505. PubMed ID: 15680071 [TBL] [Abstract][Full Text] [Related]
8. Rapid activation of the type B versus type A natriuretic factor gene by aortocaval shunt induced cardiac volume overload. Lear W; Boer PH Cardiovasc Res; 1995 May; 29(5):676-81. PubMed ID: 7606757 [TBL] [Abstract][Full Text] [Related]
9. The repressor element 1-silencing transcription factor regulates heart-specific gene expression using multiple chromatin-modifying complexes. Bingham AJ; Ooi L; Kozera L; White E; Wood IC Mol Cell Biol; 2007 Jun; 27(11):4082-92. PubMed ID: 17371849 [TBL] [Abstract][Full Text] [Related]
10. Cloning and expression of the atrial natriuretic factor gene. Nemer M; Antakly T; Argentin S; Lavigne JP; Drouin J Clin Physiol Biochem; 1988; 6(3-4):163-70. PubMed ID: 2974327 [TBL] [Abstract][Full Text] [Related]
11. Rheb activates protein synthesis and growth in adult rat ventricular cardiomyocytes. Wang Y; Huang BP; Luciani DS; Wang X; Johnson JD; Proud CG J Mol Cell Cardiol; 2008 Dec; 45(6):812-20. PubMed ID: 18722381 [TBL] [Abstract][Full Text] [Related]
12. A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy. Kishimoto I; Rossi K; Garbers DL Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2703-6. PubMed ID: 11226303 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of cdk Inhibitor p16INK4a by adenovirus vector inhibits cardiac hypertrophy in vitro and in vivo: a novel strategy for the gene therapy of cardiac hypertrophy. Nozato T; Ito H; Watanabe M; Ono Y; Adachi S; Tanaka H; Hiroe M; Sunamori M; Marum F J Mol Cell Cardiol; 2001 Aug; 33(8):1493-504. PubMed ID: 11448137 [TBL] [Abstract][Full Text] [Related]
14. [Genetics and molecular biology of cardiac hypertrophy]. Rossi G; Cecchi F G Ital Cardiol; 1995 Dec; 25(12):1643-8. PubMed ID: 8707013 [No Abstract] [Full Text] [Related]
15. Atrial natriuretic peptide gene transfection with a novel envelope vector system ameliorates pulmonary hypertension in rats. Mitani Y; Maruyama J; Jiang BH; Sawada H; Shimpo H; Imanaka-Yoshida K; Kaneda Y; Komada Y; Maruyama K J Thorac Cardiovasc Surg; 2008 Jul; 136(1):142-9. PubMed ID: 18603067 [TBL] [Abstract][Full Text] [Related]
16. Effect of AT2 blockade on cardiac hypertrophy as induced by high dietary salt in the proatrial natriuretic peptide (ANP) gene-disrupted mouse. Angelis E; Tse MY; Adams MA; Pang SC Can J Physiol Pharmacol; 2006 Jun; 84(6):625-34. PubMed ID: 16900247 [TBL] [Abstract][Full Text] [Related]
17. Diastolic dysfunction without left ventricular hypertrophy is an early finding in children with hypertrophic cardiomyopathy-causing mutations in the beta-myosin heavy chain, alpha-tropomyosin, and myosin-binding protein C genes. Poutanen T; Tikanoja T; Jääskeläinen P; Jokinen E; Silvast A; Laakso M; Kuusisto J Am Heart J; 2006 Mar; 151(3):725.e1-725.e9. PubMed ID: 16504640 [TBL] [Abstract][Full Text] [Related]
18. Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload. Nakagawa O; Ogawa Y; Itoh H; Suga S; Komatsu Y; Kishimoto I; Nishino K; Yoshimasa T; Nakao K J Clin Invest; 1995 Sep; 96(3):1280-7. PubMed ID: 7657802 [TBL] [Abstract][Full Text] [Related]
19. Class II HDACs mediate CaMK-dependent signaling to NRSF in ventricular myocytes. Nakagawa Y; Kuwahara K; Harada M; Takahashi N; Yasuno S; Adachi Y; Kawakami R; Nakanishi M; Tanimoto K; Usami S; Kinoshita H; Saito Y; Nakao K J Mol Cell Cardiol; 2006 Dec; 41(6):1010-22. PubMed ID: 17011572 [TBL] [Abstract][Full Text] [Related]
20. Molecular cloning of hamster brain and atrial natriuretic peptide cDNAs. Cardiomyopathic hamsters are useful models for brain and atrial natriuretic peptides. Tamura N; Ogawa Y; Itoh H; Arai H; Suga S; Nakagawa O; Komatsu Y; Kishimoto I; Takaya K; Yoshimasa T J Clin Invest; 1994 Sep; 94(3):1059-68. PubMed ID: 8083346 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]